Incisionless Surgeries: Envisioning The Future of Surgical Technology

Incisionless Surgeries: Envisioning The Future of Surgical Technology

Global market demand for technologies driving better balance between procedural value and volumes of incisionless surgeries

RELEASE DATE
28-Dec-2018
REGION
Global
Research Code: D886-01-00-00-00
SKU: HC03118-GL-TR_22717
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03118-GL-TR_22717

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer. Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical outcomes and costs associated with such incisionless procedures. This research service focuses on various technologies that enable hospitals to maximize the value of incisionless surgeries prescribed to patients (especially old age and critical cases), while achieving an optimal balance on the volume of procedures performed within the same premises.

The first section focuses on the current industry snapshot and segmentation of the global incisionless surgeries market. The section outlines the supplier landscape, major end-user segments and products that cater to various clinical applications. The section also brings out the critical growth factors that differentiate competitive performance and outlines the key R&PD initiatives that are necessary to achieve optimal balance between procedural volumes and value.

The second section focuses on the critical technology success factors that are necessary for hospitals to improve the value of incisionless surgeries, while optimizing their procedural volumes critical to meet revenue and business performance. The section also uncovers technology factors that are critical to retaining or enhancing procedural volumes, focusing on improved turnaround time, efficient OR use and reduced costs of laparopscopic procedures such as use of handheld microsurgical instruments.

The third section focuses on the prioritization of technology factors that contribute to procedural volumes and value, which demonstrate an optimal balance between supply of such technologies to meet the existing demand. The section also uncovers the critical business models that enable hospitals achieve their targets fixed for procedural value and volumes for various customer segments and regions.

Table of Contents

1.1 Scope of Research

1.2 Research Methodology

2.1 Key Findings: Increasing Pressure on Hospitals to Reduce Complexities Associated with Insurance/Medicare Claims

2.2 Key Findings: Competitors Focus on Developing Technologies that Enable Hospitals Balance Procedural Value and Volume

3.1 Adoption of advanced data analytics help hospitals streamline claims, procedures and turnaround time

3.2 The Global Market is Largely Dominated by Interventions for Cancer Diagnosis and Treatment

3.3 Intensity of Competitor Presence is Higher in Transoral, Transesophageal and Transluminal Procedures

3.4 Incisionless Procedures for Hearing Disorders is a Niche that Commands Higher Premium for Prescribed Procedures

3.5 Laminectomy and spine fusion procedures for treating stenosis cost much higher than other incisionless procedures

3.6 Global MedTech companies aggressively invest in early stage companies holding innovative IP in incisionless procedures

3.7 Flexibility, portability, precision and sensitivity of disease detection are factors differentiating products in the market

3.8 Lawsuit claims for transvaginal mesh impose pressure on industry players to invest in new polymer alternatives for vaginal mesh

3.9 Transluminal stents from Boston Scientific is likely to disrupt the global market, especially in the USA

3.10 Ease of access to incisionless procedures and associated costs of hospitalization impact value of care served by hospitals

3.11 Robotic surgical procedures have demonstrated better value to patients undergoing incisionless surgeries, but costs remain high

3.12 Use of Polyurethane instead of Polypropylene has been scientifically evaluated to deliver better performance of transvaginal mesh

3.13 Technology developments in transurethral procedures are focused towards treatment of benign prostatic hyperplasia (BPH)

3.14 Shear Wave Elastography (SWE) Ultrasound has been tested to be non-invasive and less expensive painless imaging technique

4.1 Invasive procedures are likely to cost higher and are largely covered through reimbursements

4.2 Wireless and contact-free wearable remote monitoring of vital signs enable old age patients to better manage prognosis and reduce hospital re-admissions

4.3 Higher demand for deep learning and big data analytics solutions to manage procedural volumes across busy care facilities

4.4 Machine learning algorithms have been demonstrated to improve productivity of hospitals by better prioritization of patients for procedures

4.5 Liquid biopsy and contact-free patient monitoring are proving to enable hospitals perform precise and accurate diagnosis

4.6 Use of handheld robotic laparoscopic surgical instrument enables hospitals balance both procedural volumes and value served

5.1 Use of recurrent neural networks in critical care facilities enables providers to manage higher procedural volumes

5.2 Use of intravenous indocyanine green to differentiate tumor cells has been clinically tested to be safe and effective in cancer diagnosis

5.3 Use of hand-held laparoscopic microsurgical instruments serve to be a cost-effective alternative to traditional robotic surgical systems

6.1 Transurethral procedures as a market segment holds very high granted and applied patents worldwide

6.2 Key Patent: Transoral Endoscopic Surgery of Upper Gastrointestinal Tract

6.3 Key Patent: Methods and Procedures for Manipulation of Overian Tissues for better Infertility treatment value

6.4 Key Patent: Using Camera for Ultrasound Imaging & Proper Transesophageal Echocardiography Probe

7.1 List of Key Industry Contacts

7.1 List of Key Industry Participants (continued)

Legal Disclaimer

Related Research
The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer. Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical outcomes and costs associated with such incisionless procedures. This research service focuses on various technologies that enable hospitals to maximize the value of incisionless surgeries prescribed to patients (especially old age and critical cases), while achieving an optimal balance on the volume of procedures performed within the same premises. The first section focuses on the current industry snapshot and segmentation of the global incisionless surgeries market. The section outlines the supplier landscape, major end-user segments and products that cater to various clinical applications. The section also brings out the critical growth factors that differentiate competitive performance and outlines the key R&PD initiatives that are necessary to achieve optimal balance between procedural volumes and value. The second section focuses on the critical technology success factors that are necessary for hospitals to improve the value of incisionless surgeries, while optimizing their procedural volumes critical to meet revenue and business performance. The section also uncovers technology factors that are critical to retaining or enhancing procedural volumes, focusing on improved turnaround time, efficient OR use and reduced costs of laparopscopic procedures su
More Information
No Index No
Podcast No
Author Arjunvasan Ambigapathy
Industries Healthcare
WIP Number D886-01-00-00-00
Is Prebook No